Jiayi Huang

Trials

Studies that name Jiayi Huang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:40 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07452458 · Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  NRG Oncology · recruiting · Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma · principal investigator
• Early Ph1
  NCT06831526 · Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

  Washington University School of Medicine · recruiting · Glioblastoma · principal investigator
• N/A
  NCT05393258 · Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

  Washington University School of Medicine · completed · Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant · principal investigator
• N/A
  NCT04975139 · Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

  Washington University School of Medicine · active not recruiting · Glioma · principal investigator
• Ph1
  NCT04757662 · Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

  Washington University School of Medicine · completed · Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV · principal investigator
• Ph1/Ph2
  NCT03604978 · Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

  National Cancer Institute (NCI) · active not recruiting · Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma · principal investigator
• Ph1
  NCT03267836 · Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma

  Washington University School of Medicine · terminated · Meningioma, Meningioma, Adult · principal investigator
• Ph2
  NCT03034135 · Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

  Cantex Pharmaceuticals · completed · Recurrent Glioblastoma · study chair
• Ph1/Ph2
  NCT02715609 · Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

  Washington University School of Medicine · completed · Glioblastoma Multiforme · principal investigator
• Ph1
  NCT02311556 · Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

  Washington University School of Medicine · completed · Brain Metastases · principal investigator
• Early Ph1
  NCT01907165 · Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide

  Washington University School of Medicine · completed · Glioblastoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 06:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NRG Oncology NCORP Research Base
  UG1CA189867 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Deborah Watkins Bruner, Lisa A. Kachnic · fiscal years 2014 to 2026
  Named on NCT07452458
• Supplement to Extend Funds for Grant #UM1CA186689 VICKtOrY Early Clinical Trials Consortium
  UM1CA186689 · NCI · YALE UNIVERSITY · PI Patricia M. LoRusso · fiscal years 2014 to 2026
  Named on NCT03604978
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
  UM1CA186704 · NCI · DUKE UNIVERSITY · PI JAMES L. ABBRUZZESE, ELIZABETH CLAIRE DEES, Andrea Wang-Gillam · fiscal years 2014 to 2019
  Named on NCT03604978